Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products.

Ippei Miyata, Atsushi Kato, Kazunobu Ouchi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2022 Nov

filter terms:

Antibody titers against the superantigen, Yersinia pseudotuberculosis-derived mitogen, suggestive of mediating Kawasaki disease-like manifestation in Y. pseudotuberculosis infections, in immunoglobulin products were evaluated. Trace, but detectable titer was demonstrated in the products. Thus, attention is required when evaluating anti-Y. pseudotuberculosis-derived mitogen IgG titers in patient sera post intravenous immunoglobulin therapy. Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Citation

Ippei Miyata, Atsushi Kato, Kazunobu Ouchi. Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022 Nov;28(11):1582-1583